CRISPR makes prostate cancer vulnerable to immunotherapy

The experimental treatment dramatically improved the effects of immunotherapy in mice and may offer hope for other hard-to-treat tumors. Comparison of whole genome sequencing with clinical targeted panel sequencing of metastatic prostate cancer: insights from real-world data.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with qualified healthcare professionals for medical decisions and treatment options.